In conjunction with the opening of a new exhibit at the Smithsonian National Museum of American History about the beginnings of the biotechnology revolution, a high-profile panel of genomics, pharmaceutical, and biomedical research luminaries took to a stage last night for a laid-back confab about the future.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.